Efficacy and Safety of Dabigatran Etexilate and Warfarin in ‘Real World’ Patients With Atrial Fibrillation: A Prospective Nationwide Cohort Study

Study Questions:

What is the safety and efficacy of anticoagulant-naïve patients with atrial fibrillation (AF) treated with dabigatran etexilate following its post-approval availability in a nationwide Danish cohort, compared to warfarin?